Investigation and management of resistant hypertension: British and Irish Hypertension Society position statement

被引：0

作者：

Luca Faconti ^{[1
]}

Jacob George ^{[2
]}

Sarah Partridge ^{[3
]}

Carmen Maniero ^{[4
]}

Abilash Sathyanarayanan ^{[5
]}

Spoorthy Kulkarni ^{[6
]}

Vikas Kapil ^{[4
]}

Alfredo Petrosino ^{[7
]}

Philip Lewis ^{[8
]}

Terry McCormack ^{[9
]}

Neil R. Poulter ^{[10
]}

Anthony Heagerty ^{[11
]}

Ian B. Wilkinson ^{[12
]}

机构：

[1] St. Thomas’ Hospital,Department of Clinical Pharmacology, King’s College London British Heart Foundation Centre

[2] University of Dundee,Division of Molecular & Clinical Medicine, School of Medicine, Ninewells Hospital & Medical School

[3] University of Sussex,Department of Primary Care and Public Health, Brighton and Sussex Medical School

[4] Queen Mary University of London,William Harvey Research Institute, Barts & The London School of Medicine & Dentistry

[5] Nottingham University Hospitals,Division of Experimental Medicine, University of Cambridge

[6] Addenbrooke’s Hospital,Barts Blood Pressure Centre of Excellence, Barts Heart Centre, St Bartholomew’s Hospital, Barts Health NHS Trust

[7] West Smithfield,London Tubular Centre, Department of Renal Medicine, University College London

[8] Royal Free Hospital,Institute of Clinical and Applied Health Research

[9] Stockport NHS Foundation Trust,Imperial Clinical Trials Unit, School of Public Health

[10] Hull York Medical School,Division of Cardiovascular Sciences, Faculty of Biology, Medicine and Health

[11] Imperial College London,undefined

[12] University of Manchester,undefined

来源：

Journal of Human Hypertension | 2025年 / 39卷 / 1期

关键词：

D O I：

10.1038/s41371-024-00983-6

中图分类号：

学科分类号：

摘要：

People living with resistant hypertension (RH) are at high risk of adverse cardiovascular events. The British and Irish Hypertension Society has identified suspected RH as a condition for which specialist guidance may improve rates of blood pressure control and help clinicians identify those individuals who may benefit from specialist review. In this position statement we provide a practical approach for the investigation and management of adults with RH. We highlight gaps in the current evidence and identify important future research questions. Our aim is to support the delivery of high-quality and consistent care to people living with RH across the UK and Ireland.

引用

页码：1 / 14

页数：13

共 50 条

[1] Investigation and management of young-onset hypertension: British and Irish hypertension society position statement
Kulkarni, Spoorthy
Faconti, Luca
Partridge, Sarah
Delles, Christian
Glover, Mark
Lewis, Philip
Gray, Asha
Hodson, Emma
Macintyre, Iain
Maniero, Carmen
McEniery, Carmel M.
Sinha, Manish D.
Walsh, Stephen B.
Wilkinson, Ian B.
JOURNAL OF HUMAN HYPERTENSION, 2024, 38 (07) : 544 - 554
[2] Adult hypertension referral pathway and therapeutic management: British and Irish Hypertension Society position statement
Lewis, Philip
George, Jacob
Kapil, Vikas
Poulter, Neil R.
Partridge, Sarah
Goodman, James
Faconti, Luca
Mccormack, Terry
Wilkinson, Ian B.
JOURNAL OF HUMAN HYPERTENSION, 2024, 38 (01) : 3 - 7
[3] Adult hypertension referral pathway and therapeutic management: British and Irish Hypertension Society position statement
Philip Lewis
Jacob George
Vikas Kapil
Neil R. Poulter
Sarah Partridge
James Goodman
Luca Faconti
Terry McCormack
Ian B. Wilkinson
Journal of Human Hypertension, 2024, 38 : 3 - 7
[4] Fibromuscular dysplasia and hypertension—a statement on behalf of the British and Irish Hypertension Society
Luca Faconti
Franca Morselli
Manish Sinha
Constantina Chrysochou
Philip J. Chowienczyk
Journal of Human Hypertension, 2021, 35 : 1051 - 1053
[5] Management of hypertensive crisis: British and Irish Hypertension Society Position document
Kulkarni, Spoorthy
Glover, Mark
Kapil, Vikas
Abrams, S. M. L.
Partridge, Sarah
McCormack, Terry
Sever, Peter
Delles, Christian
Wilkinson, Ian B.
JOURNAL OF HUMAN HYPERTENSION, 2023, 37 (10) : 863 - 879
[6] Management of hypertensive crisis: British and Irish Hypertension Society Position document
Spoorthy Kulkarni
Mark Glover
Vikas Kapil
S. M. L. Abrams
Sarah Partridge
Terry McCormack
Peter Sever
Christian Delles
Ian B. Wilkinson
Journal of Human Hypertension, 2023, 37 : 863 - 879
[7] Fibromuscular dysplasia and hypertension-a statement on behalf of the British and Irish Hypertension Society
Faconti, Luca
Morselli, Franca
Sinha, Manish
Chrysochou, Constantina
Chowienczyk, Philip J.
JOURNAL OF HUMAN HYPERTENSION, 2021, 35 (11) : 1051 - 1053
[8] COVID-19 and hypertension: risks and management. A scientific statement on behalf of the British and Irish Hypertension Society
Clark, Christopher E.
McDonagh, Sinead T. J.
McManus, Richard J.
Martin, Una
JOURNAL OF HUMAN HYPERTENSION, 2021, 35 (04) : 304 - 307
[9] COVID-19 and hypertension: risks and management. A scientific statement on behalf of the British and Irish Hypertension Society
Christopher E. Clark
Sinead T. J. McDonagh
Richard J. McManus
Una Martin
Journal of Human Hypertension, 2021, 35 : 304 - 307
[10] European guidelines on the management of hypertension: The European Society of Hypertension position statement (2009)
Mancia, Giuseppe
Laurent, Stephane
Agabiti-Rosei, Enrico
Ambrosioni, Ettore
Burnier, Michel
Caulfield, Mark J.
Cifkova, Renata
Clement, Denis
Coca, Antonio
Dominiczak, Anna
Erdine, Serap
Fagard, Robert
Farsang, Csaba
Grassi, Guido
Haller, Hermann
Heagerty, Anthony
Kjeldsen, Sverre E.
Kiowski, Wolfgang
Mallion, Jean Michel
Manolis, Athanasios
Narkiewiczu, Krzysztof
Nilsson, Peter
Olsen, Michael H.
Rahn, Karl Heinz
Redon, Josep
Rodicio, Jose
Ruilope, Luis
Schmieder, Roland E.
Struijker-Boudier, Harry A. J.
van Zwieten, Pieter A.
Viigimaa, Margus
Zanchetti, Alberto
ARTERIAL HYPERTENSION, 2010, 14 (01): : 1 - 47

← 1 2 3 4 5 →